Jury Orders Biogen To Pay $5.9M For Retaliation, Sex Discrimination Claims

Mealey's (November 18, 2019, 8:48 AM EST) -- SEATTLE — A Washington federal jury on Nov. 11 found that drug maker Biogen Inc. retaliated against a saleswoman in violation of the federal False Claims Act, 31 U.S. Code §...
To view the full article, register now.